Hanson & Doremus Investment Management Abb Vie Inc. Transaction History
Hanson & Doremus Investment Management
- $748 Million
- Q2 2025
A detailed history of Hanson & Doremus Investment Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Hanson & Doremus Investment Management holds 15,924 shares of ABBV stock, worth $3.65 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
15,924
Previous 15,981
0.36%
Holding current value
$3.65 Million
Previous $3.35 Million
11.71%
% of portfolio
0.4%
Previous 0.49%
Shares
30 transactions
Others Institutions Holding ABBV
# of Institutions
4,313Shares Held
1.3BCall Options Held
16.1MPut Options Held
10.9M-
Vanguard Group Inc Valley Forge, PA177MShares$40.6 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$31.3 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$18.3 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$12.5 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.7MShares$9.55 Billion0.52% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $405B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...